Vericel (VCEL) Other Accumulated Expenses (2013 - 2026)
Vericel (VCEL) reported Other Accumulated Expenses of $116000.0 for Q1 2026, little changed on a YoY basis from $116000.0 in Q1 2025, and little changed sequentially from $116000.0 in Q4 2025.
Vericel (VCEL) Other Accumulated Expenses (2013 - 2026) Analysis & Trends
Vericel (VCEL) has 14 years of Other Accumulated Expenses data on file, last reported at $116000.0 in Q1 2026.
- For the quarter ending Q1 2026, Other Accumulated Expenses changed 0.0% year-over-year to $116000.0; the trailing twelve-month figure through Mar 2026 stood at $116000.0 (changed 0.0% YoY), and the FY2025 full-year result was $116000.0, changed 0.0% from the prior year.
- Other Accumulated Expenses steadied at $116000.0 in Q1 2026, from $116000.0 in the prior quarter.
- In the past five years, Other Accumulated Expenses ranged from a high of $118000.0 in Q2 2025 to a low of $20000.0 in Q1 2023.
- A 5-year average of $75250.0 and a median of $78500.0 in 2022 frame the typical range for Other Accumulated Expenses.
- Across the five-year window, Other Accumulated Expenses changed 0.0% in 2022 and slumped 51.22% in 2023, its largest moves.
- Tracing VCEL's Other Accumulated Expenses over 5 years: stood at $41000.0 in 2022, then plunged by 48.78% to $21000.0 in 2023, then soared by 452.38% to $116000.0 in 2024, then changed by 0.0% to $116000.0 in 2025, then changed by 0.0% to $116000.0 in 2026.
- Business Quant data shows VCEL's Other Accumulated Expenses at $116000.0 in Q1 2026, $116000.0 in Q4 2025, and $116000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Vericel | 2.30 Bn | 2.15 Bn | 49.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 116,000.00 |
| Dec 31, 2025 | 116,000.00 |
| Sep 30, 2025 | 116,000.00 |
| Jun 30, 2025 | 118,000.00 |
| Mar 31, 2025 | 116,000.00 |
| Dec 31, 2024 | 116,000.00 |
| Jun 30, 2023 | 21,000.00 |
| Mar 31, 2023 | 20,000.00 |
| Dec 31, 2022 | 41,000.00 |
| Sep 30, 2022 | 41,000.00 |
| Jun 30, 2022 | 41,000.00 |
| Mar 31, 2022 | 41,000.00 |
| Dec 31, 2021 | 41,000.00 |
| Sep 30, 2021 | 41,000.00 |
| Jun 30, 2021 | 41,000.00 |
| Mar 31, 2021 | 41,000.00 |
| Dec 31, 2020 | 41,000.00 |
| Sep 30, 2020 | 41,000.00 |
| Jun 30, 2020 | 41,000.00 |
| Mar 31, 2020 | 41,000.00 |